Modern Healthcare: The Senate Finance Committee on Tuesday signaled interest in bolstering key points in the Trump administration's drug-pricing blueprint, including potential structural reforms for Medicare Part B and Part D.
Senators from both sides of the aisle waded into a proposal highly unpopular with physicians and hospitals, aimed at removing the incentive for providers who administer drugs under Medicare Part B to prescribe the most expensive option.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now